Back to 
BROOKFIELD Corp /ON/
BROOKFIELD Corp /ON/
MDGL
Showing 0 of 2 quarters
Position history for BROOKFIELD Corp /ON/'s holdings in MADRIGAL PHARMACEUTICALS INC
No. Brookfield exited its MDGL (Madrigal Pharmaceuticals) position in Q3 2022. Its Q2 2022 13F listed 3,075 shares worth $220,000. Brookfield first reported MDGL in Q2 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.